Included | Excluded | P-value | |
---|---|---|---|
Total | 653 (83.3) | 131 (16.7) | |
Sex, male | 360 (55.1) | 70 (53.4) | 0.722 |
Age, years | 44.3 ± 19.8 | 37.7 ± 17.4 | < 0.000 |
Age, ≥ 65 years | 125 (19.1) | 11 (9.4) | 0.012 |
Country of birth, overseas | 635 (97.2) | 114 (87.0) | 0.000 |
High TB prevalence of country of birth | 461 (70.6) | 84 (64.1) | 0.142 |
Previous TB | 37 (5.7) | 7 (5.3) | 0.884 |
Site of disease | |||
Pulmonary | 307 (47.0) | 68 (51.9) | 0.098 |
Pulmonary plus other site/s | 102 (15.6) | 11 (8.4) | |
Extra-pulmonary | 244 (37.4) | 52 (39.7) | |
Culture-based diagnosis | 520 (79.6) | 90 (68.7) | 0.006 |
Drug resistancea | |||
Pan-susceptible | 463 (89.0) | 80 (88.9) | 0.139 |
Resistant to at least one drug, but not MDR-TB | 49 (9.4) | 6 (6.7) | |
MDR-TB | 8 (1.5) | 4 (4.4) | |
eGFRb, mls | 83.6 ± 16.1 | 88.6 ± 3.8 | 0.413 |
eGFR categoriesb | |||
≥ 60 ml/min | 602 (92.1) | 7 (100.0) | 0.898 |
45–59 ml/min | 18 (2.6) | 0 (0.0) | |
30–44 ml/min | 15 (2.4) | 0 (0.0) | |
< 30 ml/min | 18 (2.9) | 0 (0.0) | |
Diabetes statusc, yes | 82 (12.6) | 5 (4.8) | 0.021 |